SomaLogic teams with leading Boston academic center to offer the SomaScan® Platform to researchers
July 08, 2021 10:00 ET
|
SomaLogic, Inc.
New York and Boulder, Colo., July 08, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a leader in proteomics technology, announced today that Beth Israel Deaconess...
SomaLogic customizable protein panels with industry-leading 7,000-plex assay now available
June 22, 2021 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., June 22, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel products are now available to...
SomaLogic launches the SomaSignal™ Proteomics for Precision Medicine Initiative with healthcare innovators: Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth
May 20, 2021 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., May 20, 2021 (GLOBE NEWSWIRE) -- SomaLogic announced today its SomaSignal™ Proteomics for Precision Medicine Initiative, the first large-scale, clinically focused partnership effort...
SomaLogic announces customizable protein panels
March 18, 2021 11:14 ET
|
SomaLogic, Inc.
BOULDER, Colo., March 18, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a global leader in proteomics technology, announced today its intention to broaden its proteomics offerings to pharma,...
SomaLogic Appoints Jason Cleveland, Ph.D. as Chief Technology Officer
January 08, 2021 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Jan. 08, 2021 (GLOBE NEWSWIRE) -- SomaLogic Inc., a global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, today announced...
SomaLogic Expands Its Commercial Capabilities with Three New Senior Leaders
January 05, 2021 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Jan. 05, 2021 (GLOBE NEWSWIRE) -- SomaLogic Inc., a privately held health information company, announced today the appointments of Angela Bakker Lee, Ph.D. as executive vice...
SomaLogic Adds $81M to Series A Financing Totaling $214M
December 22, 2020 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today...
SomaLogic Closes $121M Series A Financing Led by Casdin Capital
November 25, 2020 12:57 ET
|
SomaLogic, Inc.
BOULDER, Colo., Nov. 25, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today...
SomaLogic Announces New Collaboration with FDA to Advance Biosimilar Development
October 29, 2020 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Oct. 29, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc. announced today an agreement with the US Food and Drug Administration (FDA)’s Division of Applied Regulatory Science to evaluate the...
SomaLogic Awarded Grant from National Science Foundation Convergence Accelerator
October 13, 2020 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Oct. 13, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc. announced today that a collaborative project between SomaLogic scientists and academic researchers at the University of Chicago,...